The U.S. Big Pharma, which joined its U.K.-based counterpart GSK (GSK) in founding Haleon (HLN) in 2019, has been trimming its ownership since the Sensodyne toothpaste-maker completed its spinoff ...

In context, Haleon was created in July 2019 through the merger of GlaxoSmithKline’s (GSK) and Pfizer’s consumer healthcare divisions. In July 2022, GSK spun off Haleon as an independent public ...

Sosei Heptares has lost GSK as a partner for an inflammatory bowel disease (IBD) drug candidate GSK4381406, but says it will take the programme forward as it has significant commercial potential.